This Update is a summary of presentations from the 2009 American Academy of Ophthalmology Meeting.
More than 25,000 Ophthalmologists from around the world gather to hear about the latest advances in MD, from anti-VEGF treatments to genetics and nutrition.
MD is a complex disease with many potential causes including genetic predisposition and a host of environmental factors. This provides both challenges for treatment as well as opportunities to target new pathways to track down the cause of the disease.
It is important to understand this research is ongoing and at different stages. Clinical trials are lengthy and conducted over three phases.
Sometimes results on the progress of research are announced as a part of early trials and while these results may be promising there is often a long pathway to the outcome of all clinical trials.
In addition, new drugs and procedures do not become available to the public until they have passed strict government regulations which will include the completion of Phase III trials conducted on thousands of participants to confirm effectiveness and safety.
Researchers across the world are working on Macular Degeneration to find reasons for this disease and the answers needed.
The Foundation is proud of the many brilliant and dedicated Australian researchers who form part of this international team.
Our thanks to the AMD Alliance International for their support in producing the research update.
Research Update December 2009
To view Click here
The Foundation undertakes regular research and data collection with the client base to ascertain the needs of the people who have MD. This enables the Foundation to accurately reflect the views of those with MD, their families and their carers.
Research Grant - A specific amount of money is donated yearly to a research project related to MD.
1 December 2009